J. Stoop

发表

DX 5 + CD 4 + T cells modulate CD 4 + T cell response via inhibition of IL-12 production by DCs Chapter 6 Hanane

Huizinga, R. Toes, P. Louis‐Plence, 2016 .

Induction of Regulatory T-Cells and Interleukin-10-Producing Cells in Non-Responders to Pegylated Interferon-α Therapy for Chronic Hepatitis B

R. Binda, H. Janssen, B. Haagmans, 2007, Antiviral therapy.

Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus–specific immune response

E. Kuipers, A. Woltman, J. G. Kusters, 2007, Hepatology.

Coronaviruses as Vectors: Position Dependence of Foreign Gene Expression

P. Rottier, C. D. de Haan, H. Volders, 2003, Journal of Virology.

Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses.

John H. Robinson, J. Isaacs, C. Hilkens, 2010, Arthritis and rheumatism.

Low-strength T-cell activation promotes Th17 responses.

John H. Robinson, J. Isaacs, Steven Woods, 2010, Blood.

Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.

E. Kuipers, A. Boonstra, R. Binda, 2008, Clinical immunology.

Regulatory T Cells in Chronic Hepatitis B Virus Infection

J. Stoop, Jeroen N. Stoop, 2007 .

DX5+CD4+ T cells modulate CD4+ T‐cell response via inhibition of IL‐12 production by DCs

T. Huizinga, R. Toes, Hanane el Bannoudi, 2013, European journal of immunology.

Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis

T. Huizinga, R. Toes, L. Trouw, 2014, PloS one.

Tumor Necrosis Factor Alpha Inhibits the Suppressive Effect of Regulatory T Cells on the Hepatitis B Virus– Speciﬁc Immune Response

E. Kuipers, H. Janssen, A. Woltman, 2007 .

Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Y. Lévy, E. Riley, R. Thiébaut, 2021, NPJ vaccines.

Abatacept decreases disease activity in a absence of CD4+ T cells in a collagen-induced arthritis model

T. Huizinga, R. Toes, R. Arens, 2015, Arthritis Research & Therapy.

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

H. Schuitemaker, P. van Damme, M. McElrath, 2021, The New England journal of medicine.

Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?

C. Hilkens, J. Stoop, J. Robinson, 2011, Annals of the rheumatic diseases.

Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial

Mathieu Le Gars, H. Schuitemaker, P. van Damme, 2020, medRxiv.

The choice of adjuvant determines the cytokine profile of T cells in proteoglycan‐induced arthritis but does not influence disease severity

W. Eden, C. Hilkens, J. Stoop, 2013, Immunology.

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study

M. McElrath, S. D. De Rosa, M. Pau, 2022, PloS one.

Breach of autoreactive B cell tolerance by post-translationally modified proteins

T. Huizinga, R. Toes, L. Trouw, 2017, Annals of the rheumatic diseases.

Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system

T. Huizinga, R. Toes, G. Steiner, 2015, Annals of the rheumatic diseases.

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

H. Schuitemaker, D. Heerwegh, R. Roozendaal, 2022, npj Vaccines.

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection

E. Kuipers, C. Baan, J. G. Kusters, 2005, Hepatology.

Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B.

E. Kuipers, H. Janssen, J. G. Kusters, 2007, Virology.

Activation of human basophils by combined toll‐like receptor‐ and FcεRI‐triggering can promote Th2 skewing of naive T helper cells

T. Huizinga, R. Toes, J. Suurmond, 2014, European journal of immunology.

Ebola virus glycoprotein stimulates IL-18–dependent natural killer cell responses

A. Pollard, E. Riley, M. Snape, 2020, The Journal of clinical investigation.

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination

A. Pollard, E. Riley, M. Snape, 2019, The Journal of infectious diseases.

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

H. Schuitemaker, Yvonne Wollmann, R. Roozendaal, 2020, npj Vaccines.

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

H. Schuitemaker, Yvonne Wollmann, R. Roozendaal, 2020, NPJ vaccines.

Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile

T. Huizinga, R. Toes, J. Kuiper, 2016, Arthritis Research & Therapy.

Reduced TCR‐dependent activation through citrullination of a T‐cell epitope enhances Th17 development by disruption of the STAT3/5 balance

W. van Eden, J. Falconer, C. Hilkens, 2016, European journal of immunology.

IL-21 Enhances the Activity of the TLR–MyD88–STAT3 Pathway but Not the Classical TLR–MyD88–NF-κB Pathway in Human B Cells To Boost Antibody Production

T. Huizinga, R. Toes, J. Stoop, 2013, The Journal of Immunology.

Classical TLR STAT 3 Pathway but Not the − MyD 88 − IL-21 Enhances the Activity of the TLR

T. Huizinga, J. Stoop, E. M. Toes, 2013 .